ENT.WA(ENT.WA)
ENT.WA
No analyst ratings available
No analyst price targets available for ENT.WA
Analyst coverage may not be available for this symbol
No recent analyst actions
| Metric | FY2026E | FY2027E | FY2028E | FY2029E |
|---|---|---|---|---|
| Revenue Avg | $3.34B | $3.62B | $3.89B | $3.82B |
| Low | $3.34B | $3.62B | $3.89B | $3.82B |
| High | $3.34B | $3.62B | $3.89B | $3.82B |
| EBITDA Avg | $625M | $679M | $729M | $715M |
| Low | $625M | $679M | $729M | $715M |
| High | $625M | $679M | $729M | $715M |
| EBIT Avg | $215M | $234M | $251M | $246M |
| Low | $215M | $234M | $251M | $246M |
| High | $215M | $234M | $251M | $246M |
| Net Income Avg | $116M | $130M | $144M | — |
| Low | $116M | $130M | $144M | — |
| High | $116M | $130M | $144M | — |
| EPS Avg | $6.60 | $7.40 | $8.20 | — |
| Low | $6.60 | $7.40 | $8.20 | — |
| High | $6.60 | $7.40 | $8.20 | — |
| Analysts (Rev / EPS) | 1 / 1 | 1 / 1 | 1 / 1 | 1 / — |